Naito H - Search Results

1

Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer.

Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T. Fukuokaya W, et al. Among authors: naito h. Int J Urol. 2024 Sep 18. doi: 10.1111/iju.15585. Online ahead of print. Int J Urol. 2024. PMID: 39291802

2

A phosphodiesterase 5 inhibitor, tadalafil, suppresses stromal predominance and inflammation in a rat model of nonbacterial prostatitis.

Sugimoto M, Zhang X, Ueda N, Tsunemori H, Taoka R, Hayashida Y, Hirama H, Miyauchi Y, Matsuoka Y, Naito H, Osaki Y, Kekehi Y. Sugimoto M, et al. Among authors: naito h. BMC Urol. 2019 Oct 23;19(1):99. doi: 10.1186/s12894-019-0525-x. BMC Urol. 2019. PMID: 31646996 Free PMC article.

3

The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2.

Naito H, Kato T, Ishikawa R, Tanaka K, Ueda N, Matsuoka Y, Miyauchi Y, Taoka R, Tsunemori H, Haba R, Nishiyama Y, Sugimoto M, Kakehi Y. Naito H, et al. Urology. 2021 Mar;149:174-180. doi: 10.1016/j.urology.2020.11.039. Epub 2020 Dec 5. Urology. 2021. PMID: 33285212

4

A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer.

Kato T, Tohi Y, Honda T, Matsuda I, Osaki Y, Naito H, Matsuoka Y, Okazoe H, Taoka R, Tsunemori H, Ueda N, Sugimoto M. Kato T, et al. Among authors: naito h. Int J Urol. 2023 Mar;30(3):289-297. doi: 10.1111/iju.15102. Epub 2022 Nov 22. Int J Urol. 2023. PMID: 36415128

5

Active surveillance in younger patients with prostate cancer: clinical characteristics including longitudinal patient-reported outcomes.

Tohi Y, Kato T, Matsuda I, Honda T, Osaki Y, Naito H, Matsuoka Y, Okazoe H, Taoka R, Ueda N, Sugimoto M. Tohi Y, et al. Among authors: naito h. Jpn J Clin Oncol. 2023 Mar 30;53(4):335-342. doi: 10.1093/jjco/hyac201. Jpn J Clin Oncol. 2023. PMID: 36579759

6

A national questionnaire survey of Japanese urologists on treatment perspectives for elderly prostate cancer patients.

Kato T, Tohi Y, Honda T, Matsuda I, Osaki Y, Naito H, Matsuoka Y, Okazoe H, Taoka R, Ueda N, Sugimoto M. Kato T, et al. Among authors: naito h. Int J Urol. 2023 Aug;30(8):672-680. doi: 10.1111/iju.15203. Epub 2023 Jun 23. Int J Urol. 2023. PMID: 37350593

7

Oral 5-aminolevulinic acid administration before transurethral resection of bladder tumor induces perioperative nausea and vomiting.

Taoka R, Yamada K, Sawanobori Y, Honda T, Osaki Y, Abe Y, Naito H, Tohi Y, Matsuoka Y, Kato T, Okazoe H, Ueda N, Sugimoto M. Taoka R, et al. Among authors: naito h. Photodiagnosis Photodyn Ther. 2023 Sep;43:103707. doi: 10.1016/j.pdpdt.2023.103707. Epub 2023 Jul 13. Photodiagnosis Photodyn Ther. 2023. PMID: 37451655

8

Impact of frailty on cancer-related fatigue and quality of life in outpatients with prostate cancer: a cross-sectional study of patient-reported outcomes.

Tohi Y, Kato T, Honda T, Osaki Y, Abe Y, Naito H, Matsuoka Y, Okazoe H, Taoka R, Ueda N, Sugimoto M. Tohi Y, et al. Among authors: naito h. Jpn J Clin Oncol. 2024 Jun 1;54(6):708-715. doi: 10.1093/jjco/hyae015. Jpn J Clin Oncol. 2024. PMID: 38336460

9

Prognostic impact of histological discordance between transurethral resection and radical cystectomy.

Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y; Japanese Urological Oncology Group. Matsuda A, et al. Among authors: naito h. BJU Int. 2024 Aug;134(2):207-218. doi: 10.1111/bju.16296. Epub 2024 Feb 12. BJU Int. 2024. PMID: 38344879

10

Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study.

Taoka R, Kamada M, Izumi K, Tanimoto R, Daizumoto K, Hayashida Y, Uematsu K, Arai H, Sano T, Saito R, Hirama H, Kobayashi T, Honda T, Osaki Y, Abe Y, Naito H, Tohi Y, Matsuoka Y, Kato T, Okazoe H, Ueda N, Sugimoto M. Taoka R, et al. Among authors: naito h. Int J Clin Oncol. 2024 May;29(5):602-611. doi: 10.1007/s10147-024-02481-8. Epub 2024 Feb 28. Int J Clin Oncol. 2024. PMID: 38418804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,593 results

Search Page